(1) Background: The current criteria for defining good or bad responders to bariatric surgery based on the percentage of weight loss do not properly reflect the therapeutic impact of the main bariatric techniques. At present there is an urgent need to fill this gap and provide scientific evidence that better define the success or failure of bariatric surgery in the long term. (2) Methods: This is a retrospective database study of a prospective cohort with 5-year follow-up. We established the success or failure of bariatric surgery in terms of weight loss according to a selected criterion: (1) Halverson and Koehler; (2) Reinhold modified by Christou; (3) Biron; (4) TWL > 20%; (5) percentage of changeable weight (AWL > 35%). We analyzed sensitivity and specificity for successful weight loss. (3) Results: 223 (38.7%) patients underwent sleeve gastrectomy (LSG) and 353 (61.2%) underwent laparoscopic Roux-en-Y gastric bypass (LRYGBP). The success rates at 5 years are: EWL > 50% 464 (80%), Reinhold 436 (75.6%), Biron 530 (92%), TWL > 20% 493 (85.5%), AWL < 35% 419 (72.7); ≥50% EWL and alterable weight loss AWL > 35 were the most adequate criteria as their specificities and sensibility were far above >80%. (4) Conclusions: The present study shows how the different definitions of success or failure are inconsistent in relation to the outcomes of BS. However, there are some criteria that associate statistically significant differences for the resolution of comorbidities and show the highest sensitivity and specificity rates.
Background and Objectives: Bariatric surgery remains the gold standard treatment for morbidly obese patients. Roux-en-y gastric bypass and laparoscopic sleeve gastrectomy are the most frequently performed surgeries worldwide. Obesity has also been related to gastroesophageal reflux disease (GERD). The management of a preoperative diagnosis of GERD, with/without hiatal hernia before bariatric surgery, is mandatory. Endoscopy can show abnormal findings that might influence the final type of surgery. The aim of this article is to discuss and review the evidence related to the endoscopic findings after bariatric surgery. Materials and Methods: A systematic review of the literature has been conducted, including all recent articles related to endoscopic findings after bariatric surgery. Our review of the literature has included 140 articles, of which, after final review, only eight were included. The polled articles included discussion of the endoscopy findings after roux-en-y gastric bypass and laparoscopic sleeve gastrectomy. Results: We found that the specific care of bariatric patients might include an endoscopic diagnosis when GERD symptoms are present. Conclusions: Recent evidence has shown that endoscopic follow-up after laparoscopic sleeve gastrectomy could be advisable, due to the pathological findings in endoscopic procedures in asymptomatic patients.
In December 2019, the outbreak of SARS-CoV-2 started in mainland China, rapidly spreading across the globe. Currently, there is a global pandemic situation, and, with more or less success, countries such as Italy, Spain, France, and United States have initiated a first-level response. In this framework, the management of morbidly obese patients has been greatly affected. This article reviews the current hotspot issues and discusses different management strategies for patients with morbid obesity during the pandemic. The aim of this communication is to provide advice to bariatric/metabolic surgeons worldwide regarding the management and treatment of morbidly obese patients during this COVID-19 pandemic.
17 February 2024 in Cirugía Española (English Edition)
One of the greatest threats to public health in the 21st century is anthropogenic climate change. Healthcare services worldwide account for 4.9% of global CO2 emissions, with operating rooms being the most resource-intensive areas of the hospital. The need for environmentally sustainable change is a priority. Reliable quantitative data on emissions remain limited, which may hinder informed decision-making on surgical sustainability. The aim of this study is to develop and validate an easily accessible and user-friendly calculator to quantitatively estimate procedure-related carbon dioxide equivalent (CO2-eq) emissions of minimally invasive cholecystectomy across a range of countries, hospital volumes, and healthcare settings. The ECOMIS project follows a multiphase, stepwise design. The present study will focus on minimally invasive cholecystectomies. The calculator variables will be selected based on a systematic literature review of factors influencing CO2-eq emissions, with life cycle assessment (LCA) considered an established and comprehensive methodology for assessing CO2-eq emissions. The project will generate a comprehensive quantitative overview of the environmental impact associated with key variables involved in minimally invasive surgery. This tool has the potential to facilitate tailor-made and evidence-based decision-making and promote more sustainable surgical practices.